Suchbegriffe: PROPYLENE GLYCOLS - THERAPEUTIC USE , . Treffer: 3
Pilz, G; Harrer, A; Wipfler, P; Oppermann, K; Sellner, J; Fazekas, F; Trinka, E; Kraus, J
Tumefactive MS lesions under fingolimod: a case report and literature review.
Neurology. 2013; 81(19):1654-1658
Doi: 10.1212/01.wnl.0000435293.34351.11
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Foster, CA; Mechtcheriakova, D; Storch, MK; Balatoni, B; Howard, LM; Bornancin, F; Wlachos, A; Sobanov, J; Kinnunen, A; Baumruker, T
FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage.
Brain Pathol. 2009; 19(2):254-266
Doi: 10.1111/j.1750-3639.2008.00182.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Balatoni, B; Storch, MK; Swoboda, EM; Schönborn, V; Koziel, A; Lambrou, GN; Hiestand, PC; Weissert, R; Foster, CA
FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis.
Brain Res Bull. 2007; 74(5):307-316
Doi: 10.1016/j.brainresbull.2007.06.023
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar